Invesco Ltd. 13D and 13G filings for Veracyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-09 7:18 pm Sale |
2023-02-14 | 13G | Veracyte, Inc. VCYT |
Invesco Ltd. IVZ |
313,974 0.400% |
-3,800,057![]() (-92.37%) |
Filing |
2022-02-10 11:32 am Purchase |
2022-02-09 | 13G | Veracyte, Inc. VCYT |
Invesco Ltd. IVZ |
4,114,031 5.800% |
546,446![]() (+15.32%) |
Filing |
2021-02-12 3:34 pm Purchase |
2021-02-12 | 13G | Veracyte, Inc. VCYT |
Invesco Ltd. IVZ |
3,567,585 6.200% |
229,696![]() (+6.88%) |
Filing |